IFP Advisors Inc Raises Stock Position in Agilent Technologies, Inc. $A

IFP Advisors Inc boosted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 139.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,067 shares of the medical research company’s stock after acquiring an additional 622 shares during the period. IFP Advisors Inc’s holdings in Agilent Technologies were worth $126,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Mirae Asset Global Investments Co. Ltd. grew its stake in Agilent Technologies by 13.5% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 36,674 shares of the medical research company’s stock valued at $4,279,000 after acquiring an additional 4,362 shares in the last quarter. Alps Advisors Inc. lifted its position in Agilent Technologies by 29.5% during the first quarter. Alps Advisors Inc. now owns 13,358 shares of the medical research company’s stock valued at $1,563,000 after purchasing an additional 3,040 shares during the last quarter. D.A. Davidson & CO. lifted its position in Agilent Technologies by 30.4% during the first quarter. D.A. Davidson & CO. now owns 9,474 shares of the medical research company’s stock valued at $1,108,000 after purchasing an additional 2,207 shares during the last quarter. LGT Capital Partners LTD. lifted its position in Agilent Technologies by 7.6% during the first quarter. LGT Capital Partners LTD. now owns 768,252 shares of the medical research company’s stock valued at $89,870,000 after purchasing an additional 54,302 shares during the last quarter. Finally, Live Oak Investment Partners bought a new stake in Agilent Technologies during the first quarter valued at approximately $603,000.

Agilent Technologies Trading Up 0.6%

A opened at $142.01 on Friday. The business has a 50 day moving average of $127.58 and a 200-day moving average of $117.84. The stock has a market cap of $40.26 billion, a PE ratio of 33.34, a PEG ratio of 4.63 and a beta of 1.26. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.37. The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company’s revenue was up 10.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities research analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be paid a dividend of $0.248 per share. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 annualized dividend and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is currently 23.24%.

Analyst Ratings Changes

Several equities research analysts have issued reports on A shares. Robert W. Baird lifted their target price on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research report on Thursday, August 28th. TD Cowen boosted their price objective on shares of Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a report on Tuesday, October 14th. UBS Group upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $130.00 to $170.00 in a report on Wednesday, October 8th. Evercore ISI boosted their price objective on shares of Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a report on Tuesday, October 7th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $149.62.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.